Evidence map›Paper›PMID 41634008›Full record

ArticleNature communications2026

A microphysiological human mini-bladder reveals urine-urothelium interplay in tissue resilience and UPEC recurrence in urinary tract infections.

Gauri Paduthol, Mikhail Nikolaev, Kunal Sharma, Jérôme Blanc, Kathrin Tomasek, Léa Ivana Esméralda Schlunke, Valentin Borgeat, Giovanna Ambrosini, Irina Kolotuev, Stéphanie Clerc-Rosset and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. UropathogenicAntibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gauri Paduthol *Laboratory of Microbiology and Microtechnology, School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0002-6654-3281
Mikhail Nikolaev *Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.ORCID 0000-0001-5955-900X
Kunal SharmaLaboratory of Microbiology and Microtechnology, School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0001-8086-3436
Jérôme BlancBioElectron Microscopy Facility, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Kathrin TomasekLaboratory of Microbiology and Microtechnology, School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0003-3768-877X
Léa Ivana Esméralda SchlunkeLaboratory of Microbiology and Microtechnology, School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0009-0007-1394-0842
Valentin BorgeatLaboratory of Microbiology and Microtechnology, School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0003-2933-2458
Giovanna AmbrosiniBioinformatics Competence Centre, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0003-1294-6541
Irina KolotuevDepartment of Biomedical Sciences, Université De Lausanne, Lausanne, Switzerland.
Stéphanie Clerc-RossetBioElectron Microscopy Facility, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Nikolche GjorevskiInstitute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.ORCID 0000-0001-8320-0443
Graham W KnottBioElectron Microscopy Facility, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0002-2956-9052
Matthias P LütolfInstitute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. matthias.lutolf@roche.com.
Vivek V ThackerDepartment of Infectious Diseases, Medical Microbiology and Hygiene, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany. vivek.thacker@uni-heidelberg.de.ORCID 0000-0002-1681-627X
John D McKinneyLaboratory of Microbiology and Microtechnology, School of Life Sciences (SV), Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. john.mckinney@epfl.ch.ORCID 0000-0002-0557-3479

Funding

Bundesbehörden der Schweizerischen Eidgenossenschaft (Federal Authorities of the Swiss Confederation) 2022.0289Novartis Stiftung für Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research) 20C240Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 51NF40_180541Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) TMPFP3_217144
6 · The paper itself

Abstract

Urine is a dynamic and highly variable biofluid. Urine-urothelium interactions are a critical yet underexplored factor in bladder homoeostasis and urinary tract infections (UTIs). Here, we report on a human 'mini-bladder' model that exposes a stratified urothelium to urine of defined composition, and incorporates micturition. Prolonged exposure to high-solute concentration urine weakens tight junctions, dysregulates immune responses, and reduces bladder tissue resilience. This increases susceptibility to colonisation of the bladder by uropathogenic Escherichia coli (UPEC) which reduces efficacy of antibiotic therapy. In high-solute concentration urine, Fosfomycin monotherapy - prescribed for uncomplicated UTIs, induces the formation of cell wall-deficient (CWD) UPEC in the urine (as observed in patients with recurrent UTIs) but also within deeper urothelial layers. Tissue-associated CWD UPEC directly contributes to recurrence. Our findings expand the conceptual role for CWD UPEC in UTIs, and demonstrate the power of the mini-bladder platform to capture urine-urothelial microenvironment dynamics that actively shape UTI pathogenesis and antibiotic tolerance.

Indexed as

Escherichia coli InfectionsUrinary BladderUrinary Tract InfectionsUrineUropathogenic Escherichia coliUrotheliumAnti-Bacterial AgentsFemaleFosfomycinHumansMicrophysiological SystemsRecurrenceAnti-Bacterial AgentsFosfomycin

Identifiers

PMID41634008
PMCPMC12976268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.